• 1
    Cordoba J, Blei AT. Hepatic encephalopathy. In: SchiffE, SorrellE, SorrellM, MaddreyW, eds. Schiff's Diseases of the Liver. 9th ed. Philadelphia: Lippincott Williams and Wilkins Liver and Biliary Diseases, 2003: 595624.
  • 2
    Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2000; 22: 513.
  • 3
    Conn HO, Leevy CM, Chlacevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 1977; 72: 573583.
  • 4
    Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 47379.
  • 5
    Als-Nielsen B, Gludd LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomized trials. BMJ 2004; 328: 1046.
  • 6
    Wehler M, Kokoska J, Reulback U, Hahn E, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. HEPATOLOGY 2001; 34: 255261.
  • 7
    Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artificial Organs 1993; 17: 809813.
  • 8
    Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular Adsorbent Recycling System (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artificial Organs 1999; 23: 319330.
  • 8
    Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett R. The Molecular Adsorbents Recycling System as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trials, and clinical experiences from 19 centers. Artificial Organs 2002; 26: 103110.
  • 9
    Butterworth RF. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int 2003; 23(Suppl 3): 59.
  • 10
    Schmidt LE, Tofteng F, Strauss GI, Larsen FS. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy. Scand J Gastroenterol 2004; 39: 974980.
  • 11
    Schmidt L, Sorensen V, Svendsen L, Hansen B, Larsen FS. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001; 7: 10341039.
  • 12
    Lynch P, Hassanein T, Hilsabeck R, Stange J, Blei A. Grading hepatic encephalopathy in a controlled trial of MARS: performance of two scales [Abstract]. HEPATOLOGY 2004; 40(Suppl): 508A.
  • 13
    Heredia D, Cabelleria J, Arroyo V, Ravelli G, Rhodes J. Lacticol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE): a controlled trial. J Hepatol 1987; 4: 293298.
  • 14
    Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890895.
  • 15
    Kim WR, Gross JB, Poterucha JJ, Locke GR, Dickson ER. Outcome of hospital care in liver disease associated with hepatitis C in the United States. HEPATOLOGY 2001; 33: 201206.
  • 16
    Kamath PS, Wisner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464470.
  • 17
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716721.
  • 18
    Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. HEPATOLOGY 2002; 36: 949958.
  • 19
    Novelli G, Rossi M, Pretagostini R, Novelli L, Poli L, Ferretti G, et al. A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 2003; 23(Suppl 3): 1015.
  • 20
    Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 2001; 7: 709712.
  • 21
    Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003; 9: 290297.
  • 22
    Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, et al. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004; 18: 365371.
  • 23
    Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217222.
  • 24
    Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 2004; 10: 10991106 [Review].
  • 25
    Wechsler D. Wechsler memory scale—revised: manual. San Antonio, TX: The Psychological Corporation, 1987.
  • 26
    Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain 1999; 83: 157162.
  • 27
    Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991; 5: 125142.
  • 28
    Wechsler D. Wechsler adult intelligence scale—3rd ed. Manual, San Antonio, TX: The Psychological Corporation, 1997.
  • 29
    Benedict RHB. Brief visuospatial memory test—revised: Manual, San Antonio, TX: The Psychological Corporation, 1997.
  • 30
    Randolph C. Repeatable battery for the assessment of neuropsychological status: Manual. San Antonio, TX: The Psychological Corporation, 1998.